(Sample) age/42
type: EFO_0000001
property type: age
property value: 42

(Sample) age/61
type: EFO_0000001
property type: age
property value: 61

(Sample) clinical history/Arthralgia, Oral ulcers. Treated with Hydroxychloroquine and aspirin.
type: EFO_0000001
property type: clinical history
property value: Arthralgia, Oral ulcers. Treated with Hydroxychloroquine and aspirin.

213797_at
type: EFO_0005072
part of: A-AFFY-33

(Sample) clinical history/Deep vein thrombosis + Fetal death. Treated with Hydroxychloroquine and aspirin.
type: EFO_0000001
property type: clinical history
property value: Deep vein thrombosis + Fetal death. Treated with Hydroxychloroquine and aspirin.

(Assay) 04SE652HGU133A_201004
type: Assay
has participant: A-AFFY-33

(Sample) clinical history/Cerebral atroke, Arthritis, Anemia, Secondary APS. Treated with Hydroxychloroquine, acenocoumarol and prednison.
type: EFO_0000001
property type: clinical history
property value: Cerebral atroke, Arthritis, Anemia, Secondary APS. Treated with Hydroxychloroquine, acenocoumarol and prednison.

(Sample) disease/systemic lupus erythematosus
type: EFO_0002690
property type: disease
property value: systemic lupus erythematosus

202086_at
type: EFO_0005072
part of: A-AFFY-33

(Sample) disease/normal
type: EFO_0000761
property type: disease
property value: normal

(Assay) 04SE58HA300104
type: Assay
has participant: A-AFFY-33

(Sample) disease/primary antiphospholipid syndrome
type: EFO_0002689
property type: disease
property value: primary antiphospholipid syndrome

(Sample) age/63
type: EFO_0000001
property type: age
property value: 63

214453_s_at
type: EFO_0005072
part of: A-AFFY-33

MX1
type: EnsemblDatabaseReference

(Factor value) DISEASE/systemic lupus erythematosus
type: EFO_0002690
property type: DISEASE
property value: systemic lupus erythematosus

MX1
type: EnsemblDatabaseReference

MX1 UP in 'systemic lupus erythematosus' vs 'normal'
type: IncreasedDifferentialExpressionRatio
fold change: 1.2343281
p value: 0.0179095546281962
refers to: MX1
refers to: 202086_at
t statistic: 4.88363154517078

(Assay) 04SE61HA300104
type: Assay
has participant: A-AFFY-33

(Factor value) DISEASE/normal
type: EFO_0000761
property type: DISEASE
property value: normal

(Sample) organism part/venous blood
type: EFO_0000001
property type: organism part
property value: venous blood

(Factor value) DISEASE/primary antiphospholipid syndrome
type: EFO_0002689
property type: DISEASE
property value: primary antiphospholipid syndrome

IFI44L
type: EnsemblDatabaseReference

205483_s_at
type: EFO_0005072
part of: A-AFFY-33

(Assay) 04SE62HA300104
type: Assay
has participant: A-AFFY-33

(Sample) age/26
type: EFO_0000001
property type: age
property value: 26

(Assay) 04SE651HGU133A_201004
type: Assay
has participant: A-AFFY-33

(Assay) 04SE650HGU133A_201004
type: Assay
has participant: A-AFFY-33

Analysis of 'systemic lupus erythematosus' vs 'normal'
type: MicroarrayDifferentialExpressionAnalysis

(Assay) 04SE653HGU133A_201004
type: Assay
has participant: A-AFFY-33

(Assay) 04SE60HA300104
type: Assay
has participant: A-AFFY-33

(Assay) 04SE63HA300104
type: Assay
has participant: A-AFFY-33

(Assay) 04SE649HGU133A_201004
type: Assay
has participant: A-AFFY-33

(Sample) sex/female
type: EFO_0001265
property type: sex
property value: female

(Assay) 04SE730HGU133A_201004
type: Assay
has participant: A-AFFY-33

(Assay) 04SE728HGU133A_201004
type: Assay
has participant: A-AFFY-33

(Sample) age/27
type: EFO_0000001
property type: age
property value: 27

Homo sapiens
type: OBI_0100026

IFI44L
type: EnsemblDatabaseReference

IFI44
type: EnsemblDatabaseReference

RSAD2
type: EnsemblDatabaseReference

(Sample) age/39
type: EFO_0000001
property type: age
property value: 39

(Sample) age/53
type: EFO_0000001
property type: age
property value: 53

(Sample) age/40
type: EFO_0000001
property type: age
property value: 40

(Sample) age/44
type: EFO_0000001
property type: age
property value: 44

(Assay) 04SE66HA300104
type: Assay
has participant: A-AFFY-33

(Sample) clinical history/Cerebral atroke, Secondary APS. Treated with Hydroxychloroquine, aspirin and heparin.
type: EFO_0000001
property type: clinical history
property value: Cerebral atroke, Secondary APS. Treated with Hydroxychloroquine, aspirin and heparin.

204439_at
type: EFO_0005072
part of: A-AFFY-33

(Sample) clinical history/Acute myocardic infarct + Abortions. Treated with acenocoumarol
type: EFO_0000001
property type: clinical history
property value: Acute myocardic infarct + Abortions. Treated with acenocoumarol

(Sample) age/24
type: EFO_0000001
property type: age
property value: 24

(Sample) age/35
type: EFO_0000001
property type: age
property value: 35

(Sample) age/32
type: EFO_0000001
property type: age
property value: 32

(Assay) 04SE654HGU133A_201004
type: Assay
has participant: A-AFFY-33

(Assay) 04SE64HA300104
type: Assay
has participant: A-AFFY-33

(Sample) age/31
type: EFO_0000001
property type: age
property value: 31

RSAD2 UP in 'systemic lupus erythematosus' vs 'normal'
type: IncreasedDifferentialExpressionRatio
fold change: 1.44734632888889
p value: 0.0128492574993937
refers to: RSAD2
refers to: 213797_at
t statistic: 5.29024039223091

E-MEXP-1635
type: microarray 1colour mrna differential
RO_0002162: Homo sapiens
description: explore the transcriptome profiles of PBMCs derived from individuals with Primary antiphospholipid syndrome (PAPS) and compared them with those of healthy individuals. Also compare the transcriptome profiles of the closely related Systemic lupus Erythematosus autoimmune disorder with the same profiles from healthy individuals
uses data from: http://identifiers.org/pubmed/17960154

203153_at
type: EFO_0005072
part of: A-AFFY-33

(Sample) biosource type/fresh specimen
type: OBI_0000971
property type: biosource type
property value: fresh specimen

IFI44
type: EnsemblDatabaseReference

IFI44 UP in 'systemic lupus erythematosus' vs 'normal'
type: IncreasedDifferentialExpressionRatio
fold change: 1.35968395777778
p value: 0.0179095546281962
refers to: 214453_s_at
refers to: IFI44
t statistic: 4.84550716640301

(Sample) age/55
type: EFO_0000001
property type: age
property value: 55

(Assay) 04SE59HA300104
type: Assay
has participant: A-AFFY-33

(Assay) 04SE729HGU133A_201004
type: Assay
has participant: A-AFFY-33

IFI44L UP in 'systemic lupus erythematosus' vs 'normal'
type: IncreasedDifferentialExpressionRatio
fold change: 2.08894477777778
p value: 0.0128492574993937
refers to: IFI44L
refers to: 204439_at
t statistic: 5.27595601593112

RSAD2
type: EnsemblDatabaseReference

A-AFFY-33
type: EFO_0000269

(Sample) age/43
type: EFO_0000001
property type: age
property value: 43

IFIT1
type: EnsemblDatabaseReference

(Assay) 04SE65HA300104
type: Assay
has participant: A-AFFY-33

(Sample) clinical history/Ictus, Secondary APS. Treated with Hydroxychloroquine and aspirin.
type: EFO_0000001
property type: clinical history
property value: Ictus, Secondary APS. Treated with Hydroxychloroquine and aspirin.

(Sample) clinical history/Abortions. Treated with aspirin.
type: EFO_0000001
property type: clinical history
property value: Abortions. Treated with aspirin.

(Sample) age/37
type: EFO_0000001
property type: age
property value: 37

(Assay) 04SE57HA300104
type: Assay
has participant: A-AFFY-33

IFIT1
type: EnsemblDatabaseReference

(Sample) age/49
type: EFO_0000001
property type: age
property value: 49

(Sample) cell type/mononuclear cell
type: CL_0000842
property type: cell type
property value: mononuclear cell

(Assay) 04SE67HA300104
type: Assay
has participant: A-AFFY-33

(Sample) organism/Homo sapiens
type: Homo sapiens
property type: organism
property value: Homo sapiens

(Sample) clinical history/Cerebral stroke. Treated with aspirin and acenocoumarol
type: EFO_0000001
property type: clinical history
property value: Cerebral stroke. Treated with aspirin and acenocoumarol

IFIT1 UP in 'systemic lupus erythematosus' vs 'normal'
type: IncreasedDifferentialExpressionRatio
fold change: 1.1227884
p value: 0.0484856639823694
refers to: 203153_at
refers to: IFIT1
t statistic: 4.11971330499399

(Sample) clinical history/Photosensitivity, Arthritis, Raynaud. Treated with aspirin.
type: EFO_0000001
property type: clinical history
property value: Photosensitivity, Arthritis, Raynaud. Treated with aspirin.

ISG15
type: EnsemblDatabaseReference

ISG15
type: EnsemblDatabaseReference

ISG15 UP in 'systemic lupus erythematosus' vs 'normal'
type: IncreasedDifferentialExpressionRatio
fold change: 1.24580414444444
p value: 0.0128492574993937
refers to: 205483_s_at
refers to: ISG15
t statistic: 5.81516844314348

(Sample) age/33
type: EFO_0000001
property type: age
property value: 33